MetaCap

Monte Rosa Therapeutics (GLUE) News

NASDAQ: GLUEHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

8.64-0.27 (-3.03%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

GLUE news summary

We found 6 recent headlines mentioning Monte Rosa Therapeutics (GLUE): 0 in the past week and 6 in the past 30 days, most often from GlobeNewswire, Seeking Alpha, Nasdaq. For price context, GLUE is down 3.03% at $8.64. The most recent story, "Monte Rosa Therapeutics Presents Preclinical Data at ACR Convergence 2026 on the Potential of MRT-8102 in Gout", was published by GlobeNewswire on Nov 9, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Monte Rosa Therapeutics headlines

Stocks mentioned alongside GLUE

Compare GLUE